Standard

Нарушения сна при болезни Альцгеймера. / Колмакова, Кристина Андреевна; Лобзин, Владимир Юрьевич; Емелин, Андрей Юрьевич.

In: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, Vol. 124, No. 4-2, 29.04.2026, p. 56-62.

Research output: Contribution to journal › Article › peer-review

Harvard

Колмакова, КА, Лобзин, ВЮ & Емелин, АЮ 2026, 'Нарушения сна при болезни Альцгеймера', ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, vol. 124, no. 4-2, pp. 56-62. https://doi.org/10.17116/jnevro202612604256

APA

Колмакова, К. А., Лобзин, В. Ю., & Емелин, А. Ю. (2026). Нарушения сна при болезни Альцгеймера. ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, 124(4-2), 56-62. https://doi.org/10.17116/jnevro202612604256

Vancouver

Колмакова КА, Лобзин ВЮ, Емелин АЮ. Нарушения сна при болезни Альцгеймера. ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА. 2026 Apr 29;124(4-2):56-62. https://doi.org/10.17116/jnevro202612604256

Author

Колмакова, Кристина Андреевна ; Лобзин, Владимир Юрьевич ; Емелин, Андрей Юрьевич. / Нарушения сна при болезни Альцгеймера. In: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА. 2026 ; Vol. 124, No. 4-2. pp. 56-62.

BibTeX

@article{f9b34730486543f1941a2991521cd7e4,
title = "Нарушения сна при болезни Альцгеймера",
abstract = "This article investigates the progression of sleep disturbances in Alzheimer's disease (AD) and the mechanisms by which these disturbances may accelerate neurodegeneration. Key electrophysiological patterns identified through polysomnography in patients with AD and sleep disorders are analyzed. Therapeutic interventions are reviewed, with non-pharmacological and pharmacological approaches considered separately. The roles of cognitive behavioural therapy, relaxation techniques, and optimization of sleep conditions are emphasized. Current pharmacological treatment options are discussed, highlighting the need for careful drug selection due to the high risk of adverse effects and the potential dangers of certain medications, such as benzodiazepines and cyclopyrroles, in elderly patients with cognitive impairment. The use of memantine as a foundational therapy is given particular attention, as it may improve both cognitive function and sleep quality.",
keywords = "Alzheimer{\textquoteright}s disease, insomnia, light therapy, lymphatic system, memantine, polysomnography, sleep disorders, slow-wave sleep, β-amyloid",
author = "Колмакова, {Кристина Андреевна} and Лобзин, {Владимир Юрьевич} and Емелин, {Андрей Юрьевич}",
note = "Колмакова К.А., Лобзин В.Ю., Емелин А.Ю. Нарушения сна при болезни Альцгейме-ра. Журнал неврологии и психиатрии им. С.С. Корсакова. 2026;124(4 2):56 62. ",
year = "2026",
month = apr,
day = "29",
doi = "10.17116/jnevro202612604256",
language = "русский",
volume = "124",
pages = "56--62",
journal = "ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА",
issn = "1997-7298",
publisher = "Медицина",
number = "4-2",

}

RIS

TY - JOUR

T1 - Нарушения сна при болезни Альцгеймера

AU - Колмакова, Кристина Андреевна

AU - Лобзин, Владимир Юрьевич

AU - Емелин, Андрей Юрьевич

N1 - Колмакова К.А., Лобзин В.Ю., Емелин А.Ю. Нарушения сна при болезни Альцгейме-ра. Журнал неврологии и психиатрии им. С.С. Корсакова. 2026;124(4 2):56 62.

PY - 2026/4/29

Y1 - 2026/4/29

N2 - This article investigates the progression of sleep disturbances in Alzheimer's disease (AD) and the mechanisms by which these disturbances may accelerate neurodegeneration. Key electrophysiological patterns identified through polysomnography in patients with AD and sleep disorders are analyzed. Therapeutic interventions are reviewed, with non-pharmacological and pharmacological approaches considered separately. The roles of cognitive behavioural therapy, relaxation techniques, and optimization of sleep conditions are emphasized. Current pharmacological treatment options are discussed, highlighting the need for careful drug selection due to the high risk of adverse effects and the potential dangers of certain medications, such as benzodiazepines and cyclopyrroles, in elderly patients with cognitive impairment. The use of memantine as a foundational therapy is given particular attention, as it may improve both cognitive function and sleep quality.

AB - This article investigates the progression of sleep disturbances in Alzheimer's disease (AD) and the mechanisms by which these disturbances may accelerate neurodegeneration. Key electrophysiological patterns identified through polysomnography in patients with AD and sleep disorders are analyzed. Therapeutic interventions are reviewed, with non-pharmacological and pharmacological approaches considered separately. The roles of cognitive behavioural therapy, relaxation techniques, and optimization of sleep conditions are emphasized. Current pharmacological treatment options are discussed, highlighting the need for careful drug selection due to the high risk of adverse effects and the potential dangers of certain medications, such as benzodiazepines and cyclopyrroles, in elderly patients with cognitive impairment. The use of memantine as a foundational therapy is given particular attention, as it may improve both cognitive function and sleep quality.

KW - Alzheimer’s disease

KW - insomnia

KW - light therapy

KW - lymphatic system

KW - memantine

KW - polysomnography

KW - sleep disorders

KW - slow-wave sleep

KW - β-amyloid

UR - https://www.mendeley.com/catalogue/8ca8791e-15f6-3dc4-8a07-44a8039e6a62/

U2 - 10.17116/jnevro202612604256

DO - 10.17116/jnevro202612604256

M3 - статья

VL - 124

SP - 56

EP - 62

JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

SN - 1997-7298

IS - 4-2

ER -

ID: 153033239